Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EverywhereAire is a life sciences company founded by Harvard professor David Edwards to pioneer the field of "airborne hygiene." The company's core technology is a calcium-rich nasal mist, marketed under the brand FEND, designed to strengthen the airway's natural mucosal defense system. By altering the surface tension of the mucus lining in the upper respiratory tract, the mist prevents the breakup of mucus into tiny droplets, thereby reducing the exhalation and inhalation of potentially infectious bioaerosols. This physical intervention serves as a complementary layer of protection against respiratory pathogens, including viruses and environmental allergens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EverywhereAire.